LAURA KAUFMAN: Open Payments
NPI 1144619776 · PINEHURST, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$808 in 40 payments from 13 companies in 2025. Trend: 2023 $395 · 2024 $630 · 2025 $808
Food & beverage: $808
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $236 |
| Boston Scientific Corporation | 1 | $137 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $77 |
| Janssen Biotech, Inc. | 3 | $69 |
| Phathom Pharmaceuticals, Inc. | 6 | $65 |
| Regeneron Healthcare Solutions, Inc. | 3 | $60 |
| QOL Medical, LLC | 2 | $38 |
| PFIZER INC. | 2 | $29 |
| Ardelyx, Inc. | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
Products named: General - Therapies, RINVOQ, TREMFYA, VOQUEZNA, DUPIXENT, SKYRIZI, MAVYRET, EOHILIA.
Industry payments across NC — which companies pay providers there.
